T: 866-285-7215, 1-781-489-7301 F: 781-489-7308

sales@bccresearch.com www.bccresearch.com

Proteomics: Technologies and
Global Markets
May 2013 BIO034C
Use this report to:
Receive analysis for the main proteomic platforms: mass spectrometry and biochips, as
G
well as to receive detailed information concerning the individual market segments and
industry dynamics.
Focus on the market for proteomic-based diagnostics products, which highlight a major
G
future market segment for proteomic technologies.
Learn about the factors that influence each market, including growth-driving forces,
G
industry alliances and acquisitions, applications in diagnostics and drug discovery,
customer needs and competitive trends.
Examine the main patent trends within the industry.
G
To place an order for
Proteomics: Technologies
and Global Markets
call 866-285-7215
May 2013
Report ID: BIO034C
Highlights
The global proteomic market was worth nearly $3.7 billion in 2011 and nearly $4.2 billion in
2012, and is forecast to grow at a compound annual growth rate (CAGR) of 16.1% during the
next five years to reach nearly $8.9 billion in 2017.
This report provides:
An overview of the global proteomics market, which covers: technologies, database and
G
software markets, equipment markets, application markets and service markets.
Analyses of global market trends, with data from 2011 and 2012, and projections of
G
compound annual growth rates (CAGRs) through 2017.
Discussion of trends and opportunities, top-selling products, key players, and a competitive
G
outlook.
Comprehensive company profiles across subsegments, such as protein chip providers,
G
reagent providers, service providers, informatics and database providers, etc.
SAMPLE FIGURE
GLOBAL PROTEOMIC MARKET BY END-USE INDUSTRY, THROUGH 2017
($ MILLIONS)
To submit your query click here
Source: BCC Research

Introduction & Scope
INTRODUCTION
STUDY GOALS AND OBJECTIVES
BCC Researchs goal for this study was to determine the status of proteomic
technologies and products and assess their global growth potential over the five-year
period from 2012 to 2017. The market was analyzed for the main proteomic platforms:
mass spectrometry and biochips.
The biochip market was characterized by key biochip type (i.e., lab-on-a-chip, planar
array, bead array) and by end-use industry (e.g., research, drug discovery and
development, diagnostics, applied).
The mass spectrometry (MS) market was characterized by MS instrument type and
end-use industry, as well as by MS workflow (e.g., sample preparation, chromatography,
tagging and labeling reagents, and informatics).
A particular focus of the study is placed on the market for proteomic-based diagnostics
products, which highlights a major future market segment for proteomic technologies.
To place an order for
Proteomics: Technologies
and Global Markets
call 866-285-7215
May 2013
Report ID: BIO034C
The key objective was to present a comprehensive discussion of the main commercial
proteomic technologies, along with the current and future commercial potential for
each of the key market segments.
REASONS FOR DOING THE STUDY
BCC Research has previously examined the proteomic industry as part of several larger
studies. For example, BCC published a report on biochips in 2011 that covered protein
arrays and lab-on-a-chip (LOAC) products and markets. In 2010, BCC published a
report on next-generation cancer diagnostics that covered diagnostics applications for
proteomic biochips.
The main objective for the present report is to present the up-to-date market picture
for proteomics into a single comprehensive report. The objective was to capture the
changing industry dynamics and market shift occurring in this industry. Thus, it is
timely to examine the key aspects of the proteomic industry.
There is also an urgent need in the life science industry for technologies and products
that can analyze and study the human proteome in a high-throughput, multiplex and
low-cost way. Proteomic technologies are evolving to meet more of these needs, so it
is important to keep abreast of these dynamics.
This report is intended to inform companies in the life science industries regarding the
important trends in MS, LOAC and arrays, as well as to provide detailed information
concerning the individual market segments and industry dynamics.
CONTRIBUTION OF THE STUDY AND INTENDED AUDIENCE
BCC has compiled a study of critical proteomic technologies that are used in the four
major end-user segments: research, drug discovery and development, diagnostics and
applied markets. The report discusses the proteomic platforms, market growth driving
forces, product types, key market applications, companies and alliances, industry
dynamics, patents, future market potential and product sales forecasts for the period
from 2012 through 2017.
This study will be of particular interest to the companies in such industries as
diagnostics, pharmaceuticals, biotechnology, nanotechnology, life sciences tools,
biodefense, medical devices, analytical instruments, chromatography, chemicals,
polymers, glass and bioinformatics. It will also be of interest to companies involved in
drug, diagnostic and/or biomarker discovery programs; manufacturers of microarrays
and lab-on-a-chip devices; sample prep suppliers; bioinformatics developers; and
cancer researchers and clinicians.
SCOPE AND FORMAT
The study scope covers MS instruments, consumables, workflow products, planar
arrays, bead arrays and LOAC. It also covers the research, drug discovery and
development, diagnostics and applied end-user market segments. The main
geographical marketsNorth America, Europe, Japan and Rest of World (ROW)are
included.
The MS market is covered by instrument type, MS consumables, product type and
end-user markets. The biochip market is covered by biochip type and the-end user
market for each type. The diagnostics market is covered in some detail, including by
major platform (i.e., MS, biochips), by disease type and for cancer by indication.
This report provides the current market sizes for these segments, as well as their
forecasted growth through 2017.
Technology status and market driving forces are discussed. Factors that influence
each market are also discussed, including growth-driving forces, industry alliances and
acquisitions, applications in diagnostics and drug discovery, customer needs and
competitive trends.
To place an order for
Proteomics: Technologies
and Global Markets
call 866-285-7215
May 2013
Report ID: BIO034C
Key industry acquisitions and strategic alliances are given for the three-year period
from 2010 through 2012.
This report also examines the main patent trends within the industry and profiles 83
companies.
METHODOLOGY
Both primary and secondary research methodologies were used in preparing this
study. BCC Research examines the key end-user market segments that will be
commercially important during the next five years:
Research tools.
G
Drug discovery and development.
G
Diagnostics.
G
Applied markets (e.g., forensics, agriculture, environmental).
G
Based on this analysis, the potential applications of proteomic technologies in each of
the major market segments were evaluated, and sales revenues were forecast for the
period from 2012 through 2017.
Based on the analysis of both secondary and primary market sources, as well as the
key trends in the industry, current and projected market sizes are provided for the
various proteomic segments for 2011, 2012 and 2017.
INFORMATION SOURCES
Primary sources for this report included key industry companies and leading research
institutions. Data were also compiled from secondary sources, including company
websites and industry, trade and government publications.
ANALYST'S CREDENTIALS
John Bergin has written previous BCC Research biotechnology reports, including
Epigenomics: Emerging Opportunities in Biomarkers, Diagnostics and Therapeutics;
Global Biochip Markets: Microarrays and Lab-on-a-chip; RNA Interference in the
Post-Genomic Era: Markets and Technologies; DNA Sequencing: Emerging Technologies
and Applications; Biologic Imaging Reagents: Technologies and Global Markets; and
Synthetic Biology: Emerging Global Markets. Mr. Bergin has held business
development, sales and marketing positions with a Fortune 500 advanced materials
company, as well as executive management positions with an emerging
nanotechnology company. Mr. Bergin holds a BS in Chemistry, an MS in Biotechnology
and a Masters of Business Administration.
BCC ONLINE SERVICES
BCC offers an online information retrieval service. BCCs home page, located at
www.bccresearch.com, enables readers to:
Examine BCCs complete catalog of Market Research Reports and place direct orders.
G
Subscribe to any of BCCs many industry newsletters.
G
Read announcements of recently published reports and newly launched newsletters.
G
Register for BCCs well-known conferences.
G
Request additional information on any BCC product.
G
Take advantage of special offers.
G
DISCLAIMER
The information developed in this report is intended to be as reliable as possible at the
time of publication and of a professional nature. This information does not constitute
managerial, legal or accounting advice, nor should it serve as a corporate policy guide,
laboratory manual or an endorsement of any product, as much of the information is of
a speculative in nature. The author assumes no responsibility for any loss or damage
that might result from reliance on the reported information or from its use.
To place an order for
Proteomics: Technologies
and Global Markets
call 866-285-7215
May 2013
Report ID: BIO034C
Related Reports
BIO045D DNA Sequencing: Emerging Technologies and Applications
BIO081A Next-Generation Cancer Diagnostics: Technologies and Global Markets
NAN050A Nanobiotechnology: Applications and Global Markets
BIO049D Global Biochip Markets: Microarrays and Lab-on-a-Chip
BIO059B Epigenomics: Emerging Opportunities in Biomarkers, Diagnostics and
Therapeutics
About BCC Research
BCC Research is a leading publisher of
high-quality, technology market research
reports and technical publications. BCC
Research reports provi de quanti fi ed
measurements of the market and all major
industry segments, as well as in-depth
analysis of key market drivers and trends.
BCC Subscriptions
Access hundreds of published reports and
automatically receive newly published
research with a BCC Report Subscription.
We can tai l or a compl ete package of
material that meets your needs and budget.

BCC Custom Research
Improve your strategic planning efforts with
a BCC Custom Research study. We will work
with you to determine what information is
needed and deliver specific qualitative and
quantitative analysis that supports your
business objectives.
Call 866-285-7215 or 1-781-489-7301 (intl),
or e-mail sales@bccresearch.com for more
information about any of BCC Research`s
products and services.